Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01862848Completed

Topical Compounded Pain Creams And Pain Perception (TOPCAPP)

Role: lead

NCT02205229Suspended

Compounded Pain Preparation Absorption Study

Role: lead

NCT02394301Suspended

Efficacy of Novel Drug-combinations for Relief of Psoriasis

Role: lead

NCT01862861Completed

Relieving Vasomotor Symptoms Effectively With Bioidentical Hormone Replacement Therapy: The REVERT Study

Role: lead

All 4 trials loaded